Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy.
暂无分享,去创建一个
P. Kochanek | F. Tortella | H. Bramlett | W. D. Dietrich | R. Hayes | Kevin K. W. Wang | C. Dixon | J. Povlishock | S. Mondello | Kara E. Schmid | D. Shear | W. Dietrich | Kevin W. Wang
[1] P. Kochanek,et al. Simvastatin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[2] P. Kochanek,et al. Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[3] P. Kochanek,et al. Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[4] P. Kochanek,et al. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[5] P. Kochanek,et al. Synthesis of Findings, Current Investigations, and Future Directions: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[6] P. Kochanek,et al. Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[7] P. Kochanek,et al. Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. , 2016, Journal of neurotrauma.
[8] P. Kochanek,et al. Operation Brain Trauma Therapy: Simvastatin Treatment in Traumatic Brain Injury , 2016 .
[9] H. Bramlett,et al. Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes. , 2015, Journal of neurotrauma.
[10] D. A. Bergstrom,et al. Pre-Clinical Traumatic Brain Injury Common Data Elements: Toward a Common Language Across Laboratories. , 2015, Journal of neurotrauma.
[11] R. Vink,et al. Emerging therapies in traumatic brain injury , 2015 .
[12] Hester F. Lingsma,et al. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. , 2015, Journal of neurotrauma.
[13] S. Kernie. Cell-based therapy for pediatric traumatic brain injury: not (yet) an update to the traumatic brain injury guidelines. , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[14] C. Cox,et al. Autologous Bone Marrow Mononuclear Cells Reduce Therapeutic Intensity for Severe Traumatic Brain Injury in Children* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[15] Maiken Nedergaard,et al. Biomarkers of Traumatic Injury Are Transported from Brain to Blood via the Glymphatic System , 2015, The Journal of Neuroscience.
[16] J. Ioannidis,et al. Reproducibility in Science: Improving the Standard for Basic and Preclinical Research , 2015, Circulation research.
[17] G. Manley,et al. Classification of traumatic brain injury: past, present, and future. , 2015, Handbook of clinical neurology.
[18] David W Wright,et al. Very early administration of progesterone for acute traumatic brain injury. , 2014, The New England journal of medicine.
[19] A. Morse. Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial , 2014 .
[20] E. Wijdicks,et al. Translational research in acute central nervous system injury: lessons learned and the future. , 2014, JAMA neurology.
[21] A. Aldenkamp,et al. Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review , 2014, Seizure.
[22] S. Wisniewski,et al. Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice. , 2014, Journal of neurotrauma.
[23] J. Szaflarski,et al. Post-traumatic epilepsy: current and emerging treatment options , 2014, Neuropsychiatric disease and treatment.
[24] E. Bigler. Comment: Importance of cognitive reserve in traumatic brain injury , 2014, Neurology.
[25] H. Bramlett,et al. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury. , 2014, Journal of neurotrauma.
[26] H. Beydaği,et al. Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats , 2014, Child's Nervous System.
[27] B. Lyeth,et al. Amantadine improves cognitive outcome and increases neuronal survival after fluid percussion traumatic brain injury in rats. , 2014, Journal of neurotrauma.
[28] N. Akaike,et al. Inhibition of Excitatory Synaptic Transmission in Hippocampal Neurons by Levetiracetam Involves Zn2+-Dependent GABA Type A Receptor–Mediated Presynaptic Modulation , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[29] R. Delorenzo,et al. Mechanisms of Levetiracetam in the Control of Status Epilepticus and Epilepsy , 2014, Front. Neurol..
[30] Hester F. Lingsma,et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. , 2014, Journal of neurotrauma.
[31] P. Kochanek,et al. Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. , 2014, Journal of neurotrauma.
[32] B. Stoica,et al. Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. , 2014, Journal of neuropathology and experimental neurology.
[33] Batool F. Kirmani,et al. Clinical Pharmacology and Pharmacokinetics of Levetiracetam , 2013, Front. Neurol..
[34] América Vanoye-Carlo,et al. Synaptic vesicle protein 2A: basic facts and role in synaptic function , 2013, The European journal of neuroscience.
[35] M. Cataldi,et al. The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion , 2013, PloS one.
[36] R. Stepanović-Petrović,et al. Levetiracetam interacts synergistically with nonsteroidal analgesics and caffeine to produce antihyperalgesia in rats. , 2013, The journal of pain : official journal of the American Pain Society.
[37] G. Ling,et al. Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients , 2013, Front. Neurol..
[38] A. Shetty. Prospects of Levetiracetam as a Neuroprotective Drug Against Status Epilepticus, Traumatic Brain Injury, and Stroke , 2013, Front. Neurol..
[39] P. Kochanek,et al. Therapeutic Hypothermia Decreases Phenytoin Elimination in Children with Traumatic Brain Injury* , 2013, Critical care medicine.
[40] Ranjit S. Chima,et al. Differences in Medical Therapy Goals for Children With Severe Traumatic Brain Injury—An International Study , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[41] P. Kochanek,et al. Polynitroxylated-Pegylated Hemoglobin Attenuates Fluid Requirements and Brain Edema in Combined Traumatic Brain Injury Plus Hemorrhagic Shock in Mice , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] Heidi E Kirsch,et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.
[43] F. Tortella,et al. Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury. , 2013, Journal of neurotrauma.
[44] A. Wagner,et al. Neuroprotective, Neuroplastic, and Neurobehavioral Effects of Daily Treatment With Levetiracetam in Experimental Traumatic Brain Injury , 2013, Neurorehabilitation and neural repair.
[45] Ramona Hicks,et al. Therapy development for diffuse axonal injury. , 2013, Journal of neurotrauma.
[46] S. Wisniewski,et al. Effect of Hyperoxia on Resuscitation of Experimental Combined Traumatic Brain Injury and Hemorrhagic Shock in Mice , 2013, Anesthesiology.
[47] P. Kochanek,et al. The Potential for Bio-Mediators and Biomarkers in Pediatric Traumatic Brain Injury and Neurocritical Care , 2013, Front. Neurol..
[48] C. Balaban,et al. Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study , 2013, PloS one.
[49] S. Wisniewski,et al. Mri Assessment of Cerebral Blood Flow after Experimental Traumatic Brain Injury Combined with Hemorrhagic Shock in Mice , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] Erin S. Barry,et al. Neurobehavioral, cellular, and molecular consequences of single and multiple mild blast exposure , 2012, Electrophoresis.
[51] G. Ling,et al. Time‐dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury , 2012, Electrophoresis.
[52] A. Gabrielli,et al. Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury , 2012, Brain injury.
[53] RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational Research , 2012, Translational Stroke Research.
[54] S. Wisniewski,et al. Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice. , 2012, Journal of neurotrauma.
[55] Benjamin J. Whalley,et al. The Synaptic Vesicle Glycoprotein 2A Ligand Levetiracetam Inhibits Presynaptic Ca2+ Channels through an Intracellular Pathway , 2012, Molecular Pharmacology.
[56] P. Kochanek,et al. Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. , 2012, Journal of Neurotrauma.
[57] J. Long,et al. Acute Minocycline Treatment Mitigates the Symptoms of Mild Blast-Induced Traumatic Brain Injury , 2012, Front. Neur..
[58] Robin O Cleveland,et al. Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model , 2012, Science Translational Medicine.
[59] F. Tortella,et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention , 2012, The journal of trauma and acute care surgery.
[60] R. Bullock,et al. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. , 2012, Journal of neurotrauma.
[61] C. Begley,et al. Drug development: Raise standards for preclinical cancer research , 2012, Nature.
[62] A. Pitkänen,et al. Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. , 2012, Journal of neurotrauma.
[63] N. Kissoon,et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. , 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[64] John Whyte,et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. , 2012, The New England journal of medicine.
[65] Chad J. Donahue,et al. Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice. , 2012, Journal of neurotrauma.
[66] E. Hall,et al. Translational spinal cord injury research: preclinical guidelines and challenges. , 2012, Handbook of clinical neurology.
[67] N. Marklund,et al. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? , 2011, British journal of pharmacology.
[68] P. Kochanek,et al. A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy. , 2011, The Journal of trauma.
[69] G. Ling,et al. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. , 2011, Journal of neurotrauma.
[70] Valerian Kagan,et al. Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury. , 2011, Journal of neurotrauma.
[71] D. Creery,et al. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[72] P. Kochanek,et al. Polynitroxylated pegylated hemoglobin: A novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice* , 2011, Critical care medicine.
[73] G. Clifton,et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial , 2011, The Lancet Neurology.
[74] F. Tortella,et al. Electrocortical pathology in a rat model of penetrating ballistic-like brain injury. , 2011, Journal of neurotrauma.
[75] A. Wagner,et al. Dilantin therapy in an experimental model of traumatic brain injury: effects of limited versus daily treatment on neurological and behavioral recovery. , 2011, Journal of neurotrauma.
[76] R. Gold,et al. Anti‐inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation , 2011, British journal of pharmacology.
[77] M. Bullock,et al. Critical appraisal of neuroprotection trials in head injury: What have we learned? , 2011, NeuroRX.
[78] H. Bramlett,et al. Post‐traumatic seizure susceptibility is attenuated by hypothermia therapy , 2010, The European journal of neuroscience.
[79] F. Tortella,et al. Longitudinal characterization of motor and cognitive deficits in a model of penetrating ballistic-like brain injury. , 2010, Journal of neurotrauma.
[80] D. McArthur,et al. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy , 2010, Neurology.
[81] A. Fenton,et al. Minocycline Synergizes with N-Acetylcysteine and Improves Cognition and Memory Following Traumatic Brain Injury in Rats , 2010, PloS one.
[82] E. Yan,et al. Animal models of traumatic brain injury: is there an optimal model to reproduce human brain injury in the laboratory? , 2010, Injury.
[83] J. Szaflarski,et al. Prospective, Randomized, Single-Blinded Comparative Trial of Intravenous Levetiracetam Versus Phenytoin for Seizure Prophylaxis , 2010, Neurocritical care.
[84] J. Simard,et al. Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant Stroke , 2010, Stroke.
[85] P. Kochanek,et al. Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice. , 2009, Journal of neurotrauma.
[86] H. Reichmann,et al. Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke , 2009, Stroke.
[87] D. Prough,et al. Blast-induced brain injury and posttraumatic hypotension and hypoxemia. , 2009, Journal of neurotrauma.
[88] P. Kochanek,et al. Hemorrhagic shock after experimental traumatic brain injury in mice: effect on neuronal death. , 2009, Journal of neurotrauma.
[89] Rocco Armonda,et al. Explosive blast neurotrauma. , 2009, Journal of neurotrauma.
[90] Shlomo Ta'asan,et al. Multiplex Assessment of Serum Biomarker Concentrations in Well-Appearing Children With Inflicted Traumatic Brain Injury , 2009, Pediatric Research.
[91] G. Manley,et al. Classification of traumatic brain injury for targeted therapies. , 2008, Journal of neurotrauma.
[92] H. Bramlett,et al. Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats , 2008, Experimental Neurology.
[93] Rachel P Berger,et al. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making , 2008, Current opinion in critical care.
[94] P. Kochanek,et al. Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system , 2007, Critical care medicine.
[95] F. Tortella,et al. Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat , 2007, Journal of Neuroinflammation.
[96] H. Winn,et al. Magnesium for neuroprotection after traumatic brain injury , 2007, The Lancet Neurology.
[97] M. Morganti-Kossmann,et al. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration , 2007, Experimental Neurology.
[98] Susan S. Margulies,et al. Inflicted Childhood Neurotrauma: New Insight into The Detection, Pathobiology, Prevention, and Treatment of Our Youngest Patients with Traumatic Brain Injury , 2007 .
[99] R. Hamm,et al. A review of pharmacological treatments used in experimental models of traumatic brain injury , 2007, Brain injury.
[100] F. Tortella,et al. Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration. , 2006, Journal of neurotrauma.
[101] G. Ling,et al. Severity level and injury track determine outcome following a penetrating ballistic-like brain injury in the rat , 2006, Neuroscience Letters.
[102] M. Hoane,et al. Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. , 2006, Journal of neurotrauma.
[103] N. Marklund,et al. Evaluation of pharmacological treatment strategies in traumatic brain injury. , 2006, Current pharmaceutical design.
[104] A. Pitkänen,et al. Animal models of post-traumatic epilepsy. , 2006, Journal of neurotrauma.
[105] Junling Gao,et al. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage , 2006, Neurocritical care.
[106] A. Michael,et al. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum , 2005, Journal of neurochemistry.
[107] F. Tortella,et al. Characterization of a new rat model of penetrating ballistic brain injury. , 2005, Journal of neurotrauma.
[108] E. Hall,et al. Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. , 2005, Journal of neurotrauma.
[109] C. Goldfrad,et al. Calcium channel blockers for acute traumatic brain injury. , 2003, The Cochrane database of systematic reviews.
[110] S. Wisniewski,et al. Acute etomidate treatment reduces cognitive deficits and histopathology in rats with traumatic brain injury , 2003, Critical care medicine.
[111] Helen M. Bramlett,et al. Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats , 2002, Acta Neuropathologica.
[112] P. Kochanek,et al. The simple model versus the super model: translating experimental traumatic brain injury research to the bedside. , 2001, Journal of neurotrauma.
[113] S. Wisniewski,et al. Isoflurane improves long-term neurologic outcome versus fentanyl after traumatic brain injury in rats. , 2000, Journal of neurotrauma.
[114] Brian D. Hale,et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[115] M. Bullock,et al. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. , 1999, Neurosurgery.
[116] P. Kochanek,et al. One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. , 1999, Journal of neurotrauma.
[117] D. Marion,et al. Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. , 1999, Restorative neurology and neuroscience.
[118] Lennart Persson,et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury , 1998 .
[119] J. Gobert,et al. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. , 1998, European journal of pharmacology.
[120] F. Angileri,et al. Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat. , 1998, Journal of neurotrauma.
[121] W. Löscher,et al. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. , 1998, The Journal of pharmacology and experimental therapeutics.
[122] W. Young,et al. Endogenous Repair after Spinal Cord Contusion Injuries in the Rat , 1997, Experimental Neurology.
[123] E. J. Green,et al. Temporal and Regional Patterns of Axonal Damage following Traumatic Brain Injury: A Beta‐amyloid Precursor Protein Immunocytochemical Study in Rats , 1997, Journal of neuropathology and experimental neurology.
[124] E. J. Green,et al. Hippocampally dependent and independent chronic spatial navigational deficits following parasagittal fluid percussion brain injury in the rat , 1997, Brain Research.
[125] J. Wilberger,et al. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. , 1996, JAMA.
[126] T R Holford,et al. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. , 1996, Journal of neurotrauma.
[127] A. Marmarou,et al. A new model of diffuse brain injury in rats. Part II: Morphological characterization. , 1994, Journal of neurosurgery.
[128] Ronald L. Hayes,et al. A controlled cortical impact model of traumatic brain injury in the rat , 1991, Journal of Neuroscience Methods.
[129] L. Pitts,et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.
[130] J. Miller,et al. The outcome from severe head injury with early diagnosis and intensive management. , 1977, Journal of neurosurgery.